youtube_live
Q3 2026 earnings • released • EPS beat +7.77% • Revenue beat +2.93%
See resultschevron_right
GH:NASDAQ
Guardant Health Inc
$ 158.66
arrow_upward
+5.16%(+7.79) 1D
11-р сарын 9, 16:00:00 (GMT-5) · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
$ 152.78
High
$ 162.96
Low
$ 149.40
Mkt. cap
21.29 тэрбум
Avg. vol.
2.00 сая
Volume
2.50 сая
52-wk high
$ 191.05
52-wk low
$ 74.55
EPS
-$ 3.68
Beta
1.67
Shares outstanding
135.29 сая
No. of employees
2 мян
Open
$ 152.78
High
$ 162.96
Low
$ 149.40
Mkt. cap
21.29 тэрбум
Avg. vol.
2.00 сая
Volume
2.50 сая
52-wk high
$ 191.05
52-wk low
$ 74.55
EPS
-$ 3.68
Beta
1.67
Shares outstanding
135.29 сая
No. of employees
2 мян
News stories
From web sources and news partners
Yahoo Finance
·
10 цагийн өмнө
GH Q3 2026 deep dive: new product launches and coverage wins drive growth, but market cautious on profitability
GuruFocus
·
3 өдрийн өмнө
Guardant Health Stocks Fall 9.49% as Cash Burn Outlook Rises Des
Yahoo Finance
·
3 өдрийн өмнө
Guardant Health, Inc. Q3 2026 Earnings Call Summary
Investing.com
·
3 өдрийн өмнө
Guardant Health stock reiterated at Buy by BTIG after Q3 beat
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5 мян
Founded2012
HeadquartersPalo Alto, Калифорни, Америкийн Нэгдсэн Улс
SectorHealth Care
IndustryHealth care provider
Websiteguardanthealth.com